Ledger.Open graph →
SEC Form D · filed May 24, 2019

Aardvark Therapeutics, Inc

Offering
$15.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Tien-Li Lee · San Diego, CAExec · DirectorJeffrey Chi · San Diego, CADirectorBob Shin · San Diego, CADirectorIan Hossfeld · San Diego, CADirectorAlejandra T. Alvarez Aznar · Wilmington, DEDirectorLino D. Flores Hidalgo · Wilmington, DEExec · DirectorSteven J. Paggioli · New York, NYDirectorEric W. Falkeis · New York, NYExec · DirectorKathleen T. Barr · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗